Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Franziska Günl, Angeles Mecate‐Zambrano, Selina Rehländer, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1052-1052
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 409
Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2336-2342
Open Access | Times Cited: 82
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 64
SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies
Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1263-1263
Open Access | Times Cited: 2
Development and applications of mRNA treatment based on lipid nanoparticles
Zhe Wang, Wanting Ma, Xingxing Fu, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108130-108130
Closed Access | Times Cited: 32
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Antonio Barreiro, Antoni Prenafeta, G. Bech-Sàbat, et al.
iScience (2023) Vol. 26, Iss. 3, pp. 106126-106126
Open Access | Times Cited: 21
DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice
Jinni Chen, Yao Deng, Baoying Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
Aileen Faist, Sebastian Schloer, Angeles Mecate‐Zambrano, et al.
Antiviral Research (2022) Vol. 209, pp. 105475-105475
Open Access | Times Cited: 28
Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
Qianqian Li, Mingjie Zhang, Ziteng Liang, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 26
Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity
Aline da Rocha Matos, Bráulia Costa Caetano, João Luiz de Almeida Filho, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 23
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
Aileen Faist, Josua Janowski, Sriram Kumar, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2198-2198
Open Access | Times Cited: 23
The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19
Cristina Borralleras, Javier Castrodeza, Pilar Arrazola, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. 5, pp. 507-515
Open Access | Times Cited: 12
Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study
María Jesús López Fernández, M. Vázquez, Melchor Álvarez‐Mon, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
Ramesh Kandimalla, Pratik Chakraborty, V. Jayalakshmi, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1740-1740
Open Access | Times Cited: 24
Role of available COVID-19 vaccines in reducing deaths and perspective for next generation vaccines and therapies to counter emerging viral variants: an update
Mohd Wahid, Arshad Jawed, Raju K. Mandal, et al.
Minerva Medica (2023) Vol. 114, Iss. 5
Closed Access | Times Cited: 7
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
Antoni Prenafeta, G. Bech-Sàbat, Alexandra Moros, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107224-107224
Open Access | Times Cited: 7
A comparative analysis on the safety and efficacy of Covaxin versus other vaccines against COVID-19: a review
Abhijita Talukder, Chayanika Kalita, Nayanika Neog, et al.
Zeitschrift für Naturforschung C (2022) Vol. 77, Iss. 7-8, pp. 351-362
Open Access | Times Cited: 10
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines
Md. Jamal Hossain, Ali A. Rabaan, Abbas Al Mutair, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 9
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease
Yvon Deschambault, Jessie Lynch, Bryce M. Warner, et al.
Journal of Virology (2022) Vol. 96, Iss. 9
Open Access | Times Cited: 9
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
Harnessing filamentous phages for enhanced stroke recovery
Yang Li, Kaidi Yang, De-cai Kong, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
Safety and immunogenicity of PHH-1V as booster vaccination through the Omicron era: results from a phase IIb open-label extension study up to 6 months
María Jesús López, M.M. Vazquez, M. Álvarez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Mental Health Outcomes and Sleep Status among Patients with Coronavirus Disease 2019
Mahsa Nahidi, Naghmeh Mokhber, Farideh Sinichi, et al.
Iranian Journal of Psychiatry (2022)
Open Access | Times Cited: 4
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Antonio Barreiro, Antoni Prenafeta, G. Bech-Sàbat, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves
Aminur Rahman, Kumar Jyotirmoy Roy, Gautam Kumar Deb, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13130-13130
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top